Total TRI releases
Total TRI releases at North Haven have more than three-quarters since 2010 (through 2024).
City · TRI 2024
North Haven, Connecticut Pollution
6 TRI facilities inside the city limits and 0 public water systems serving residents. In-city TRI releases more than halved year over year (-91%). Toxic releases concentrations have more than halved since 2010.
FIPS 0954940 · population 24,179 · New Haven County
Anomaly engine
Notable Signals
Pollutant pathways
North Haven Pollutant Multi-Year Trends
PM2.5 annual mean (NAAQS 9 µg/m³ (annual))Health riskFine inhalable particles 2.5 micrometers or smaller. They travel deep into the lungs and into the bloodstream — linked to asthma, heart disease, stroke, and premature death.
PM2.5 annual mean (NAAQS 9 µg/m³ (annual)) concentrations have more than halved since 2010.
PM2.5 24-hour 98th percentile (NAAQS 35 µg/m³ (24-hour))Health riskFine inhalable particles 2.5 micrometers or smaller. They travel deep into the lungs and into the bloodstream — linked to asthma, heart disease, stroke, and premature death.
PM2.5 24-hour 98th percentile (NAAQS 35 µg/m³ (24-hour)) concentrations have more than halved since 2010.
Ozone 8-hour 4th-highest daily max (NAAQS 0.070 ppm (8-hour))Health riskGround-level ozone (smog) forms when vehicle and industrial emissions react in sunlight. Inflames the airways, triggers asthma attacks, and worsens heart and lung disease.
Ozone 8-hour 4th-highest daily max (NAAQS 0.070 ppm (8-hour)) concentrations have fallen 10% since 2010.
NO₂ annual mean (NAAQS 53 ppb (annual))Health riskA tailpipe and combustion gas. Concentrates near busy roads and industrial sites; raises risk of airway inflammation, asthma, and lower respiratory infections in children.
NO₂ annual mean (NAAQS 53 ppb (annual)) concentrations have fallen 39% since 2010.
Lifetime cancer risk all pollutants (100 in a million (EPA elevated threshold))Health riskEPA-modeled added cancer cases per million residents from a lifetime of breathing local air toxics. EPA flags 100-in-a-million as elevated.
Single-vintage exposure modeling — EPA cadence is multi-year, so no trend line yet.
Formaldehyde ambient mean (0.077 µg/m³ (1-in-a-million URE))Health riskAn air toxic emitted by refineries, wood products, and combustion. EPA classifies it as a known human carcinogen — long-term inhalation raises cancer risk.
Single-vintage exposure modeling — EPA cadence is multi-year, so no trend line yet.
Benzene ambient mean (0.13 µg/m³ (1-in-a-million URE))Health riskAn air toxic from gasoline, refineries, and tobacco smoke. A known human carcinogen — chronic exposure is linked to leukemia and other blood cancers.
Single-vintage exposure modeling — EPA cadence is multi-year, so no trend line yet.
TRI air releases (5.1 fugitive + 5.2 stack)Health riskToxic chemicals reported by industrial facilities as released into the air — fugitive leaks plus smokestack emissions. Higher pounds means more inhaled exposure for nearby residents.
TRI air releases (5.1 fugitive + 5.2 stack) volumes here are too small to anchor a multi-year trend; YoY movement is still shown above.
TRI water releases (5.3)Health riskToxic chemicals reported by industrial facilities as discharged to surface waters (rivers, lakes, the ocean). Affects fishing, recreation, and downstream drinking-water intakes.
TRI water releases (5.3) volumes here are too small to anchor a multi-year trend; YoY movement is still shown above.
TRI land + off-site releasesHealth riskToxic chemicals released to land on-site or transferred off-site for disposal — landfills, deep-well injection, and similar. Risks groundwater contamination over time.
TRI land + off-site releases volumes here are too small to anchor a multi-year trend; YoY movement is still shown above.
Greenhouse gases (GHGRP large emitters, through 2023)Health riskGreenhouse gases reported by large industrial emitters under EPA's GHGRP, in metric tons of CO₂ equivalent. Drives climate warming and the heat-related health effects that follow.
Greenhouse gases (GHGRP large emitters, through 2023) concentrations are roughly unchanged from 2010.
Top facilities · TRI 2024
Largest Emitters Inside The City
| Facility | Top chemical | Total releases | YoY |
|---|---|---|---|
| Linde Advanced Material Technologies INC.Linde INC | PropyleneHealth riskSimple asphyxiant; low direct toxicity at typical exposure levels. (NIOSH) | 324 lb | -36% |
| Ulbrich Wire INCUlbrich Stainless Steels & Special Metals INC | NickelHealth riskNickel compounds are IARC Group 1 carcinogens; inhalation exposure raises lung and nasal cancer risk. (IARC) | 218 lb | +100826% |
| O.F. Mossberg & Sons INC.Of Mossberg & Sons INC | LeadHealth riskNeurotoxin. Even low childhood exposure impairs cognitive development; chronic adult exposure damages kidneys and the cardiovascular system. (EPA, ATSDR) | 166 lb | +137% |
| Covidien LPMedtronic INC | Ethylene oxideHealth riskIARC Group 1 carcinogen. Causes lymphoid and breast cancers; potent mutagen. (IARC, EPA) | 55 lb | -99% |
| Byk USA INC.Byk USA INC | Xylene (mixed isomers)Health riskEye, skin, and respiratory irritant; central-nervous-system effects from chronic exposure. (EPA) | 1 lb | -100% |
| Jensen Industries INC. | LeadHealth riskNeurotoxin. Even low childhood exposure impairs cognitive development; chronic adult exposure damages kidneys and the cardiovascular system. (EPA, ATSDR) | 0 lb | 0% |
Equity context · ACS 2018-2022 · USEPA-clone EJ disparity
Who Lives In North Haven
North Haven, Connecticut (Census place block groups): 24,179 residents. Why we surface this →
6.2%
Low-income
18.4%
People of color
4.4%
Under age 5
23.0%
Over age 64
Source: Census ACS 2018-2022 (5-year) + USEPA-clone EJ blockgroup stats (raw indicators + EJ disparity mirror).
Health context
Co-Located Health Indicators
Modeled adult-prevalence estimates published by CDC PLACES, paired with this city's pollution and demographic context. Comparisons are ecological, not causal — pollution and disease prevalence covary at the area level, but the data does not attribute any individual's diagnosis to local exposure. How this section works →
Adult asthma (current)
10.2%
CDC PLACES · 2025 release · BRFSS 2022-2023
COPD prevalence
5.2%
CDC PLACES · 2025 release · BRFSS 2022-2023
Coronary heart disease
6.2%
CDC PLACES · 2025 release · BRFSS 2022-2023
Diabetes (diagnosed)
9.3%
CDC PLACES · 2025 release · BRFSS 2022-2023
Frequent mental distress
13.9%
CDC PLACES · 2025 release · BRFSS 2022-2023
PLACES uses BRFSS-modeled small-area estimates, not individual records. Crude prevalence shown above is the local rate as published; comparators are age-adjusted vs the Connecticut mean and the US mean — both population-weighted across counties — so geographies with different age structures stay apples-to-apples. Sources: CDC PLACES · 2025 release · BRFSS 2022-2023.
Sources.
- EPA Toxics Release Inventory · retrieved 2026-05-07.
- EPA Safe Drinking Water Information System · retrieved 2026-05-07.